Literature DB >> 8461241

Sydenham's chorea: a new look at an old disease.

A al-Eissa1.   

Abstract

Eight children with Sydenham's chorea were studied to illustrate the clinical characteristics and the outcome of the disease. Their ages ranged from 8 to 13 years and the male to female ratio was 1.7:1. Most of them had hemichorea, which frequently affected the right side of the body. The common presenting manifestations were involuntary movements, facial grimacing, clumsiness, and emotional instability. The duration of chorea ranged from one week to three years, with a median of 11 weeks. One half of the patients had associated mild carditis. Recurrences of chorea occurred only among patients who were not maintained on continuous penicillin prophylaxis. Haloperidol seemed to be an effective and tolerable agent in controlling the motor manifestations of the disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8461241

Source DB:  PubMed          Journal:  Br J Clin Pract        ISSN: 0007-0947


  5 in total

1.  An update on the treatment of Sydenham's chorea: the evidence for established and evolving interventions.

Authors:  Kathleen G Walker; Jo M Wilmshurst
Journal:  Ther Adv Neurol Disord       Date:  2010-09       Impact factor: 6.570

2.  Rheumatic chorea in northern Australia: a clinical and epidemiological study.

Authors:  J R Carapetis; B J Currie
Journal:  Arch Dis Child       Date:  1999-04       Impact factor: 3.791

3.  The pattern of acute rheumatic fever in children: Experience at the children's hospital, Riyadh, Saudi Arabia.

Authors:  Mansour Al Qurashi
Journal:  J Saudi Heart Assoc       Date:  2009-10

4.  Sydenham chorea in a 5-year-old Saudi patient.

Authors:  Amer A Lardhi
Journal:  Neurosciences (Riyadh)       Date:  2014-07       Impact factor: 0.906

Review 5.  Therapeutic aspects of Sydenham's Chorea: an update.

Authors:  Greta Depietri; Niccolo Carli; Attilio Sica; Domenico Oliviero; Giorgio Costagliola; Pasquale Striano; Alice Bonuccelli; Flavia Frisone; Diego Peroni; Rita Consolini; Thomas Foiadelli; Alessandro Orsini
Journal:  Acta Biomed       Date:  2022-03-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.